This HTML5 document contains 38 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n7http://linked.opendata.cz/resource/drugbank/drug/DB04261/identifier/pubchem-substance/
n13http://linked.opendata.cz/resource/drugbank/drug/DB04261/identifier/drugbank/
n11http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n4http://linked.opendata.cz/resource/drugbank/drug/DB04261/identifier/chebi/
n14http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n5http://linked.opendata.cz/ontology/drugbank/
n6http://linked.opendata.cz/resource/drugbank/property/
n8http://linked.opendata.cz/resource/drugbank/drug/DB04261/identifier/pdb/
xsdhhttp://www.w3.org/2001/XMLSchema#
n15http://linked.opendata.cz/resource/drugbank/drug/DB04261/identifier/kegg-compound/
n9http://linked.opendata.cz/resource/drugbank/drug/DB04261/identifier/pubchem-compound/

Statements

Subject Item
n2:DB04261
rdf:type
n5:Drug
n5:group
experimental
owl:sameAs
n11:DB04261 n14:DB04261
dcterms:title
Carbamic Acid
adms:identifier
n4:28616 n7:46508652 n8:OUT n9:277 n13:DB04261 n15:C01563
n5:synthesisReference
Werner Daum, "Preparation of benzimidazol-2-yl-carbamic acid alkyl esters." U.S. Patent US3933846, issued May, 1939.
n5:IUPAC-Name
n6:271B4984-363D-11E5-9242-09173F13E4C5
n5:InChI
n6:271B498A-363D-11E5-9242-09173F13E4C5
n5:Molecular-Formula
n6:271B4989-363D-11E5-9242-09173F13E4C5
n5:Molecular-Weight
n6:271B4986-363D-11E5-9242-09173F13E4C5
n5:Monoisotopic-Weight
n6:271B4987-363D-11E5-9242-09173F13E4C5
n5:SMILES
n6:271B4988-363D-11E5-9242-09173F13E4C5
n5:Water-Solubility
n6:271B4982-363D-11E5-9242-09173F13E4C5
n5:logP
n6:271B4983-363D-11E5-9242-09173F13E4C5 n6:271B4980-363D-11E5-9242-09173F13E4C5
n5:logS
n6:271B4981-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Acceptor-Count
n6:271B4990-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Donor-Count
n6:271B4991-363D-11E5-9242-09173F13E4C5
n5:InChIKey
n6:271B498B-363D-11E5-9242-09173F13E4C5
n5:Polar-Surface-Area--PSA-
n6:271B498C-363D-11E5-9242-09173F13E4C5
n5:Polarizability
n6:271B498E-363D-11E5-9242-09173F13E4C5
n5:Refractivity
n6:271B498D-363D-11E5-9242-09173F13E4C5
n5:Rotatable-Bond-Count
n6:271B498F-363D-11E5-9242-09173F13E4C5
n5:casRegistryNumber
463-77-4
n5:Bioavailability
n6:271B4995-363D-11E5-9242-09173F13E4C5
n5:Ghose-Filter
n6:271B4997-363D-11E5-9242-09173F13E4C5
n5:MDDR-Like-Rule
n6:271B4998-363D-11E5-9242-09173F13E4C5
n5:Number-of-Rings
n6:271B4994-363D-11E5-9242-09173F13E4C5
n5:Physiological-Charge
n6:271B4993-363D-11E5-9242-09173F13E4C5
n5:Rule-of-Five
n6:271B4996-363D-11E5-9242-09173F13E4C5
n5:Traditional-IUPAC-Name
n6:271B4985-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-acidic-
n6:271B4992-363D-11E5-9242-09173F13E4C5